Ironwood Pharmaceuticals (IRWD) Accumulated Depreciation & Amortization: 2010-2024
Historic Accumulated Depreciation & Amortization for Ironwood Pharmaceuticals (IRWD) over the last 3 years, with Dec 2024 value amounting to $8.4 million.
- Ironwood Pharmaceuticals' Accumulated Depreciation & Amortization fell 5.89% to $8.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was $37.6 million, marking a year-over-year decrease of 8.37%. This contributed to the annual value of $1.2 million for FY2024, which is negligibly% changed negligibly from last year.
- Latest data reveals that Ironwood Pharmaceuticals reported Accumulated Depreciation & Amortization of $8.4 million as of Q4 2024, which was down 5.89% from $8.9 million recorded in Q4 2023.
- In the past 5 years, Ironwood Pharmaceuticals' Accumulated Depreciation & Amortization registered a high of $11.8 million during Q4 2020, and its lowest value of $8.4 million during Q4 2024.
- In the last 3 years, Ironwood Pharmaceuticals' Accumulated Depreciation & Amortization had a median value of $8.9 million in 2023 and averaged $9.3 million.
- In the last 5 years, Ironwood Pharmaceuticals' Accumulated Depreciation & Amortization grew by 17.09% in 2020 and then decreased by 18.44% in 2021.
- Ironwood Pharmaceuticals' Accumulated Depreciation & Amortization (Quarterly) stood at $11.8 million in 2020, then declined by 18.44% to $9.6 million in 2021, then rose by 11.80% to $10.8 million in 2022, then dropped by 17.42% to $8.9 million in 2023, then decreased by 5.89% to $8.4 million in 2024.
- Its last three reported values are $8.4 million in Q4 2024, $8.9 million for Q4 2023, and $10.8 million during Q4 2022.